Wiam Belkaïd

1.3k total citations
33 papers, 672 citations indexed

About

Wiam Belkaïd is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wiam Belkaïd has authored 33 papers receiving a total of 672 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wiam Belkaïd's work include Cancer Immunotherapy and Biomarkers (16 papers), Radiomics and Machine Learning in Medical Imaging (9 papers) and Gut microbiota and health (5 papers). Wiam Belkaïd is often cited by papers focused on Cancer Immunotherapy and Biomarkers (16 papers), Radiomics and Machine Learning in Medical Imaging (9 papers) and Gut microbiota and health (5 papers). Wiam Belkaïd collaborates with scholars based in Canada, United States and France. Wiam Belkaïd's co-authors include David Colman, Julie Malo, Bertrand Routy, Dalinda Liazoghli, Arielle Elkrief, Corentin Richard, Peter Thostrup, Meriem Messaoudene, Gopakumar Gopalakrishnan and Weisong Shan and has published in prestigious journals such as Science, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Wiam Belkaïd

30 papers receiving 667 citations

Peers

Countries citing papers authored by Wiam Belkaïd

Since Specialization

Citations

This map shows the geographic impact of Wiam Belkaïd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wiam Belkaïd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wiam Belkaïd more than expected).

Fields of papers citing papers by Wiam Belkaïd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wiam Belkaïd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wiam Belkaïd. The network helps show where Wiam Belkaïd may publish in the future.

Co-authorship network of co-authors of Wiam Belkaïd

This figure shows the co-authorship network connecting the top 25 collaborators of Wiam Belkaïd. A scholar is included among the top collaborators of Wiam Belkaïd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wiam Belkaïd. Wiam Belkaïd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study) 2025 ·Current Oncology ·(unknown), (unknown), Raafat Alameddine, Marie Florescu, Mustapha Tehfé, Bertrand Routy, Arielle Elkrief, Wiam Belkaïd, Antoine Desîlets, Xiaoduan Weng, (unknown), Félix Blanc‐Durand, (unknown), Goulnar Kasymjanova, Jason Agulnik, Normand Blais	1
2	Coupling culturomics and metagenomics sequencing to characterize the gut microbiome of patients with cancer treated with immune checkpoint inhibitors 2025 ·Gut Pathogens ·Khoudia Diop, (unknown), (unknown), (unknown), Myriam Benlaïfaoui, Julie Malo, A. Renaud, Wiam Belkaïd, (unknown), (unknown), Karla A. Lee, Arielle Elkrief, Bertrand Routy	2
3	Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients 2025 ·Journal of Translational Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Andréanne Gagné, Florence Blais, (unknown), Julie Malo, Wiam Belkaïd, Arielle Elkrief, Drew F. K. Williamson, Bertrand Routy, Philippe Joubert, Mathieu Laplante, Steve Bilodeau, Venkata Manem	1
4	The Cross-Scale Association between Pathomics and Radiomics Features in Immunotherapy-Treated NSCLC Patients: A Preliminary Study 2024 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Fabien C. Lamaze, Michèle Orain, François Coulombe, Julie Malo, Wiam Belkaïd, Bertrand Routy, Philippe Joubert, Philippe Després, Venkata Manem	5
5	CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC 2024 ·JTO Clinical and Research Reports ·Antoine Desîlets, (unknown), Wiam Belkaïd, (unknown), Julie Malo, (unknown), (unknown), (unknown), (unknown), J. C. A. Stagg, Marie Florescu, Mustapha Tehfé, Normand Blais, Samer Tabchi, Jean Chalaoui, (unknown), Arielle Elkrief, Vincent Quoc‐Huy Trinh, Bertrand Routy, Moïshe Liberman	2
6	Feature Tokenizer-Transformers with Self-Training for The Prediction of PD-L1 Expression of Non-Small Cell Lung Cancer from CT 2024 ·PolyPublie (École Polytechnique de Montréal) ·(unknown), (unknown), (unknown), Julie Malo, Wiam Belkaïd, Meriem Messaoudene, Nicole Bouchard, (unknown), Philippe Joubert, Houda Bahig, Simon Turcotte, Bertrand Routy, Samuel Kadoury	0
7	Multi-institutional prognostic modeling of survival outcomes in NSCLC patients treated with first-line immunotherapy using radiomics 2024 ·Journal of Translational Medicine ·(unknown), (unknown), (unknown), (unknown), Michèle Orain, François Coulombe, Julie Malo, Wiam Belkaïd, Bertrand Routy, Philippe Joubert, Venkata Manem	7
8	Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy 2023 ·Archives of Microbiology ·Khoudia Diop, (unknown), Awa Diop, Myriam Benlaïfaoui, Wiam Belkaïd, Julie Malo, Ève Bernet, Frédéric J. Veyrier, (unknown), Yves V. Brun, Arielle Elkrief, Bastien Castagner, Bertrand Routy, Corentin Richard	2
9	Tractidigestivibacter montrealensis sp. nov., a new member of human gut microbiota isolated from a healthy volunteer 2023 ·FEMS Microbiology Letters ·Myriam Benlaïfaoui, Corentin Richard, Awa Diop, Sabrine Naimi, Wiam Belkaïd, Ève Bernet, Frédéric J. Veyrier, Arielle Elkrief, Louis‐Marie Bobay, Bertrand Routy, Khoudia Diop	1
10	A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study 2023 ·Cancers ·(unknown), (unknown), (unknown), (unknown), Fabien C. Lamaze, Michèle Orain, François Coulombe, Julie Malo, Wiam Belkaïd, Bertrand Routy, Philippe Joubert, Venkata Manem	11
11	The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy 2023 ·Cancer Treatment and Research Communications ·(unknown), Bertrand Routy, (unknown), Wiam Belkaïd, Danh Tran‐Thanh, Julie Malo, (unknown), (unknown), Marie Florescu, Mustapha Tehfé, Normand Blais	11
12	Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), Michèle Orain, François Coulombe, Julie Malo, Wiam Belkaïd, Bertrand Routy, Philippe Joubert, Venkata Manem	15
13	CN12 Impact of diet on immune checkpoint blockade: Nurse-directed dietary intervention 2022 ·Annals of Oncology ·J. Malo, Myriam Benlaïfaoui, (unknown), Meriem Messaoudene, Wiam Belkaïd, Arielle Elkrief, (unknown), (unknown), Marie Florescu, (unknown), (unknown), Valérie Marcil, Bertrand Routy, Corentin Richard	1
14	A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC) 2021 ·Cancer Treatment and Research Communications ·(unknown), Pierre-Olivier Gaudreau, Wiam Belkaïd, Marie Florescu, Normand Blais	1
15	Venous thrombotic events in patients treated with immune checkpoint inhibitors for non-small cell lung cancer: A retrospective multicentric cohort study 2021 ·Thrombosis Research ·Xavier Deschênes‐Simard, Corentin Richard, Loïck Galland, Florence Blais, Antoine Desîlets, Julie Malo, (unknown), Wiam Belkaïd, Arielle Elkrief, Andréanne Gagné, (unknown), Michèle Orain, Philippe Joubert, François Ghiringhelli, Bertrand Routy, Normand Blais	44
16	Physiologic colonic uptake of 18F-FDG on PET/CT is associated with clinical response and gut microbiome composition in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Corentin Richard, Lisa Derosa, (unknown), Julie Malo, Meriem Messaoudene, Antoine Desîlets, Wiam Belkaïd, Arielle Elkrief, Bertrand Routy, Daniel Juneau	20
17	Cellular response to micropatterned growth promoting and inhibitory substrates 2013 ·BMC Biotechnology ·Wiam Belkaïd, Peter Thostrup, Patricia T. Yam, Camille A. Juźwik, Edward S. Ruthazer, Ajit Singh Dhaunchak, David Colman	13
18	N-Cadherin Prodomain Processing Regulates Synaptogenesis 2012 ·Journal of Neuroscience ·Analı́a Reinés, Louis‐Philippe Bernier, (unknown), Wiam Belkaïd, Weisong Shan, Alexander Koch, Philippe Séguéla, David Colman, Ajit Singh Dhaunchak	31
19	Lipidome and proteome map of myelin membranes 2012 ·Journal of Neuroscience Research ·Gopakumar Gopalakrishnan, (unknown), Wiam Belkaïd, Omar de Faria, Dalinda Liazoghli, David Colman, Ajit Singh Dhaunchak	46
20	Rapid Assembly of Functional Presynaptic Boutons Triggered by Adhesive Contacts 2009 ·Journal of Neuroscience ·Anna Lisa Lucido, (unknown), Peter Thostrup, Adam V. Kwiatkowski, Sergio Leal‐Ortiz, Gopakumar Gopalakrishnan, Dalinda Liazoghli, Wiam Belkaïd, R. Bruce Lennox, Peter Grütter, Craig C. Garner, David Colman	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact